Review
World J Hepatol
9(5):227-241.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.227
Abstract (1079)
|
Core Tip (1042)
|
Full Article (HTML) (8345)
|
Figures (1-1) (290)
|
Tables (1-1) (260)
|
Full Article (PDF)-1022K (988)
|
Audio-1185K (31)
|
Peer-Review Report-93K (382)
|
Answering Reviewers-394K (246)
|
Received: 11/14/2016
|
Revised: 11/22/2016
|
Accepted: 12/09/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (51)
|
Total Visits (17960)
|
Similar Articles (161)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
World J Hepatol
9(5):242-251.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.242
Abstract (1453)
|
Core Tip (1124)
|
Full Article (HTML) (4357)
|
Tables (1-9) (453)
|
Full Article (PDF)-848K (633)
|
Audio-1509K (17)
|
Peer-Review Report-106K (237)
|
Answering Reviewers-143K (243)
|
Received: 08/29/2016
|
Revised: 10/12/2016
|
Accepted: 12/09/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (28)
|
Total Visits (13049)
|
Similar Articles (87)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
World J Hepatol
9(5):252-262.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.252
Abstract (1114)
|
Core Tip (1023)
|
Full Article (HTML) (2980)
|
Figures (1-3) (257)
|
Tables (1-6) (259)
|
Full Article (PDF)-1040K (400)
|
Audio-1650K (24)
|
Peer-Review Report-138K (200)
|
Answering Reviewers-120K (162)
|
Received: 08/22/2016
|
Revised: 10/23/2016
|
Accepted: 01/14/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (12781)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study
World J Hepatol
9(5):263-269.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.263
Abstract (991)
|
Core Tip (1154)
|
Full Article (HTML) (3804)
|
Figures (1-1) (249)
|
Tables (1-3) (277)
|
Full Article (PDF)-887K (511)
|
Audio-529K (36)
|
Peer-Review Report-163K (315)
|
Answering Reviewers-193K (300)
|
Received: 08/13/2016
|
Revised: 09/12/2016
|
Accepted: 12/09/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (25)
|
Total Visits (15718)
|
Similar Articles (256)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
World J Hepatol
9(5):270-277.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.270
Abstract (1270)
|
Core Tip (1118)
|
Full Article (HTML) (3528)
|
Figures (1-2) (317)
|
Tables (1-3) (286)
|
Full Article (PDF)-1001K (517)
|
Audio-659K (29)
|
Peer-Review Report-111K (182)
|
Answering Reviewers-75K (188)
|
Received: 11/13/2016
|
Revised: 12/15/2016
|
Accepted: 01/14/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (19)
|
Total Visits (14091)
|
Similar Articles (135)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
World J Hepatol
9(5):278-287.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.278
Abstract (1321)
|
Core Tip (1021)
|
Full Article (HTML) (4962)
|
Figures (1-3) (499)
|
Tables (1-2) (287)
|
Full Article (PDF)-1017K (644)
|
Audio-209K (24)
|
Peer-Review Report-121K (227)
|
Answering Reviewers-168K (230)
|
Received: 11/16/2016
|
Revised: 12/14/2016
|
Accepted: 01/03/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (24)
|
Total Visits (14418)
|
Similar Articles (318)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?
World J Hepatol
9(5):288-292.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.288
Abstract (897)
|
Core Tip (1211)
|
Full Article (HTML) (2542)
|
Figures (1-2) (591)
|
Full Article (PDF)-825K (270)
|
Audio-1441K (16)
|
Peer-Review Report-107K (147)
|
Answering Reviewers-98K (149)
|
Received: 09/27/2016
|
Revised: 12/04/2016
|
Accepted: 12/19/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (9738)
|
Similar Articles (240)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open